发明名称 EXAMINATION METHOD FOR PREDICTING PROGNOSIS AFTER ADMINISTERING GEMCITABINE HYDROCHLORIDE TO PANCREATIC CANCER PATIENT
摘要 PROBLEM TO BE SOLVED: To provide an examination method for predicting the prognosis of a pancreatic cancer patient after administering gemcitabine hydrochloride to the patient. SOLUTION: The examination method for predicting the prognosis of a pancreatic cancer patient after administering gemcitabine hydrochloride to the patient includes detecting the polymorphism and/or mutation of ABCC1 gene encoding a relevant transporter; wherein the single nucleotide polymorphism in the ABCC1 gene is at least (1): rs4148335, (2): rs4148336 or (3): rs4148340. COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2009261357(A) 申请公布日期 2009.11.12
申请号 JP20080116933 申请日期 2008.04.28
申请人 JAPAN HEALTH SCIENCE FOUNDATION 发明人 SAIJO NAGAHIRO;FURUSE JUNJI;ISHII HIROSHI;OKUSAKA TAKUSHI;UENO HIDEKI;SATO YASUNORI;YOSHIDA TERUHIKO;SAWADA JUNICHI;SAITO YOSHIAKI;KANIWA NAHOKO
分类号 C12Q1/68;C12N15/09 主分类号 C12Q1/68
代理机构 代理人
主权项
地址